Shantel
Key Takeaways:
- Resonetics, a leading medical contract design and manufacturing organization, has announced the appointment of Todd Trapp as Chief Financial Officer (CFO).
- Trapp brings deep expertise in financial management, team-building, and experience in the medical device industry.
- As CFO, Trapp will focus on elevating Resonetics’ financial operations, implementing scalable processes, and supporting the company’s continued growth.
About Resonetics
Resonetics is a pioneer in advanced engineering, product development, prototyping, and manufacturing solutions for the medical technology (MedTech) and life sciences industry. With four core business units specializing in Interventional, Advanced Diagnostics, Minimally Invasive Surgery, and Embedded Technologies, the company offers a wide range of capabilities. Resonetics is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, microfluidics, sensor solutions, and medical power. The company is ISO 13485:2016 certified and operates 14 facilities across the United States, Canada, Costa Rica, Israel, and Switzerland. Resonetics is backed by leading private equity firms Carlyle and GTCR.
Appointment of Todd Trapp as CFO
Todd Trapp has been appointed as Chief Financial Officer of Resonetics. Trapp brings a wealth of experience in financial management, team-building, and the medical device industry. Prior to joining Resonetics, Trapp served as Executive Vice President and CFO for Abiomed, a leading provider of cardiovascular medical technology with a revenue of $1 billion. In that role, he was responsible for finance, information technology, customer service, and communications. Trapp also served as CFO of Watts Water Technologies, a global leader in innovative water control products with a revenue of $2 billion. He spent 13 years at Honeywell International in various senior financial and operational leadership roles.
Kevin D Kelly, President, and CEO of Resonetics expressed his excitement about Trapp joining as CFO, emphasizing his expertise, track record in building teams, and experience in the medical device industry. Kelly believes Trapp’s appointment will help elevate Resonetics’ financial operations and implement scalable processes to support the company’s continued growth.
Todd Trapp shared his enthusiasm about joining Resonetics as CFO, recognizing the company’s leadership in micro manufacturing for the medical device and life sciences industries. He expressed his commitment to contribute to the company’s success by capitalizing on market opportunities, driving operational excellence, and ensuring sustainable growth.
About Resonetics
Founded in 1987, Resonetics is a pioneer in advanced engineering, product development, prototyping, and manufacturing solutions for the MedTech and life sciences industry. The company operates in four core business units: Interventional, Advanced Diagnostics, Minimally Invasive Surgery, and Embedded Technologies. Resonetics is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, microfluidics, sensor solutions, and medical power. With 14 facilities and over 2,000 associates across the United States, Canada, Costa Rica, Israel, and Switzerland, Resonetics is committed to quality, speed, innovation, and exceptional customer experience. The company is ISO 13485:2016 certified and is backed by leading private equity firms Carlyle and GTCR.
For more information about Resonetics, please visit www.resonetics.com.
